Skip to main content
Farmacosmo logo

Farmacosmo — Investor Relations & Filings

Ticker · ZJ1 ISIN · IT0005487670 LEI · 815600ABEDB6F0BDDE28 XMIL Wholesale and retail trade
Open in API
Filings indexed 188 across all filing types
Latest filing 2022-04-29 Capital/Financing Update
Country IT Italy
Listing XMIL ZJ1

About Farmacosmo

https://www.farmacosmo.com/

Farmacosmo is an e-commerce company that operates an online platform for health, beauty, and personal care products. The company's core business is the online sale of a broad range of items, including parapharmaceuticals, supplements, cosmetics, personal care products, baby supplies, and pet care essentials. Managing its platform in-house, Farmacosmo offers a catalog of over 80,000 products from various brands. The company aims to provide a comprehensive wellness destination by combining the offerings of a pharmacy and a cosmetics retailer, supported by expert advice from professionals.

Recent filings

Filing Released Lang Actions
Farmacosmo: Esercizio Parziale Dell’Opzione Greenshoe
Capital/Financing Update Classification · 98% confidence The document is a press release dated April 29, 2022, titled "FARMACOSMO: ESERCIZIO PARZIALE DELL'OPZIONE GREENSHOE" (Farmacosmo: Partial Exercise of the Greenshoe Option). It details a specific corporate action related to the stabilization mechanism following a public offering (the exercise of the Greenshoe option and the return of borrowed shares). This type of announcement, which concerns capital structure adjustments or post-offering mechanics, fits best under Capital/Financing Update (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it pertains to a specific financing/capital event. The document length (7572 chars) is substantial enough to be the primary announcement, not just a notice of publication (RPA).
2022-04-29 Italian
Farmacosmo: Comunicazione Finale Dell’attivita’ Di Stabilizzazione
Regulatory Filings Classification · 99% confidence The document is a formal communication titled "Farmacosmo: Comunicazione Finale Dell'attivita' Di Stabilizzazione" (Farmacosmo: Final Communication of Stabilization Activity). It details transactions (purchases) conducted by an appointed entity (illimity Bank S.p.A.) related to the company's shares (ISIN IT0005487670) over a specific period (March 30, 2022 – April 29, 2022), referencing EU Regulation 2016/1052. This activity relates to managing the share price following an offering, which falls under financing or capital market activities. Since the document is a final report/communication about stabilization activities, it is best classified as a Capital/Financing Update (CAP). It is not a general earnings release (ER), a full annual report (10-K), or a general regulatory filing (RNS), as it pertains to a specific capital market operation.
2022-04-29 Italian
Farmacosmo: l’assemblea approva il bilancio 2021 e la distribuzione del dividendo
Notice of Dividend Amount Classification · 98% confidence The document is a press release dated April 29, 2022, announcing the resolutions passed by the Shareholders' Meeting (Assemblea degli Azionisti). The key resolutions concern the approval of the 2021 Financial Statements (Bilancio 2021) and the distribution of a dividend (€0.01 per share). While it discusses the financial results (Revenues, EBITDA, Net Income) and the dividend, its primary function, as indicated by the structure and the header 'COMUNICATO STAMPA' (Press Release), is to announce the outcomes of the shareholder meeting where the annual accounts were approved. The approval of the annual accounts and the subsequent dividend decision are core components of an Annual General Meeting (AGM) outcome announcement. Since the document explicitly details the approval of the 'bilancio 2021' by the 'Assemblea' and the resulting dividend distribution, it strongly aligns with the scope of an AGM-related announcement, even though it contains financial highlights. Given the options, 'AGM-R' (AGM Information) is the most appropriate classification for the official announcement of AGM resolutions, which includes the approval of the annual report and dividend declaration, rather than classifying it as the full 10-K or just an Earnings Release (ER). The document is too detailed to be a simple RPA, as it contains the substance of the decisions, not just a notice that a report is available.
2022-04-29 Italian
Farmacosmo: Fabio de Concilio - modello di notifica di comunicazione al pubblico delle operazioni effettuate da chiunque detiene azioni
Director's Dealing Classification · 100% confidence The document is a formal notification filed with Euronext Growth Milan, dated April 26, 2022. The subject ('Oggetto') is 'di notifica di comunicazione al pubblico delle operazioni effettuate da chiunque detiene azioni' (notification of public communication of transactions carried out by any person holding shares). The template used is explicitly titled 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.' This directly corresponds to reporting insider transactions by directors/executives. The specific code for this type of filing is 'DIRS' (Director's Dealing).
2022-04-26 Italian
Farmacosmo: Internal Dealing VAR S.r.l.
Director's Dealing Classification · 100% confidence The document is titled 'Modello di notifica e di comunicazione al pubblico delle operazioni effettuate da persone che esercitano funzioni di amministrazione, di controllo o di direzione e da persone a loro strettamente associate' (Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them). The subject line explicitly mentions 'Farmacosmo: Internal Dealing VAR S.r.l.'. 'Internal Dealing' refers to transactions by insiders (directors, management, or closely associated persons). This directly corresponds to the definition of Director's Dealing (insider trades). Although the text says 'Vedi allegato' (See attachment), the document itself is the standardized notification form for insider transactions, making it a specific regulatory filing related to insider trading, which maps best to the 'Director's Dealing' category.
2022-04-25 Italian
FARMACOSMO: RISULTATI DEL PRIMO TRIMESTRE RICAVI + 20% YoY A € 17,7 MLN CRESCONO TUTTI I KPI SUL PORTALE FARMACOSMO.IT
Earnings Release Classification · 95% confidence The document is a press release from Farmacosmo S.p.A. dated April 22, 2022. It contains two main components: 1) A summary of Q1 2022 financial performance (revenue growth and KPIs), which qualifies as an Earnings Release (ER), and 2) An announcement regarding the initiation of a share buyback program (POS). Given that the primary purpose of the document is to announce the quarterly financial results (as indicated by the headline 'RISULTATI DEL PRIMO TRIMESTRE'), it is best classified as an Earnings Release. Q1 2022
2022-04-22 Italian

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.